Stories indexed under: Stem cells

Total: 76   RSS feed

• WiCell Research Institute launches new stem cell bank Aug. 21, 2008 The WiCell Research Institute, a private, not-for-profit supporting organization to the University of Wisconsin-Madison, is launching its own stem cell bank to distribute cell lines beyond the 21 lines eligible for federal funding and distribution through the National Stem Cell Bank (NSCB).
• World Stem Cell Summit offers registration discounts to UW-Madison community Aug. 13, 2008 The Stem Cell and Regenerative Medicine Center and the WiCell Research Institute will help supplement World Stem Cell Summit registrations for a limited number of faculty, staff, students and trainees.
• New $8.9 million project aims to unlock stem cell secrets Aug. 4, 2008 Although scientists have had access to human embryonic stem cells for a decade, precisely how the all-purpose cell gives rise to all other cells in the body and why others do not remains a fundamental mystery of biology.
• New $8.9 million project aims to unlock stem cell secrets Aug. 4, 2008 Although scientists have had access to human embryonic stem cells for a decade, precisely how the all-purpose cell gives rise to all other cells in the body and why others do not remains a fundamental mystery of biology.
• Recent sightings: Stem cell summer science camp July 20, 2008
• Scientific information largely ignored when forming opinions about stem cell research June 5, 2008 When forming attitudes about embryonic stem cell research, people are influenced by a number of things. But understanding science plays a negligible role for many people, according to a recent UW-Madison study.
• Invitrogen, WARF sign license agreement for human embryonic stem cells May 8, 2008 Invitrogen Corp. and the Wisconsin Alumni Research Foundation announced today (May 8) that they have signed a license for human embryonic stem cell (hESC) patents for the development of research tools.
• Professor wins inaugural Schuster Prize May 8, 2008 Timothy Kamp, a professor of medicine and physiology at the University of Wisconsin School of Medicine and Public Health, has been awarded the inaugural Schuster Prize for excellence in advancing cardiovascular medicine at the school.
• Time Magazine names James Thomson one of “World’s Most Influential People” May 2, 2008 Stem cell scientist James Thomson has been named one of Time magazine's "World's Most Influential People," with Shinya Yamanaka of Kyoto University. Last year, they each discovered a way to give human skin cells many of the characteristics of embryonic stem cells, an advance that avoids the destruction of embryos.
• Stem cell pioneer Thomson elected to National Academy of Sciences April 29, 2008 Pioneering University of Wisconsin-Madison stem cell scientist James Thomson was elected today (April 29) to the National Academy of Sciences.
• Leading scientists to highlight annual stem cell research symposium April 11, 2008 A cadre of North America's leading stem cell scientists will land in Madison April 16 for the third annual Wisconsin Stem Cell Symposium.
• Erik Forsberg appointed executive director of WiCell Research Institute April 9, 2008 Erik Forsberg has been named to the newly created position of executive director of the WiCell Research Institute. In this position, Forsberg will direct all operations of the private, non-profit institute, a supporting organization of the University of Wisconsin-Madison that provides core services to UW-Madison stem cell researchers and operates the National Stem Cell Bank.
• Christopher and Dana Reeve Foundation chair to speak at Stem Cell Summit April 2, 2008 Peter D. Kiernan, III, chair of the Christopher and Dana Reeve Foundation, will provide the keynote address at the World Stem Cell Summit Sept. 22-23, 2008, at the Alliant Energy Center in Madison.
• For stem cell scientist James Thomson, discovery trumps fame March 24, 2008 The UW scientist who first brought stem cells into the scientific spotlight — a discovery that sparked a volatile debate of political and medical ethics — doesn’t seek fame for himself. So when you are the go-to guy for everybody who wants access to James Thomson, a man who’d much rather be in the lab than in the media’s glare, you learn to say no more often than you’d like.
• Stem cell summit to convene in Madison March 12, 2008 Researchers, business representatives, philanthropists, bioethicists and educators from around the world will be invited to Madison for the World Stem Cell Summit at the Alliant Energy Center on Sept. 22-23, 2008.
• California company licenses WARF stem cell technology Jan. 9, 2008 BioTime, Inc. (OTCBB: BTIM) has signed a licensing agreement with the Wisconsin Alumni Research Foundation (WARF) for 173 patents and patent applications relating to human embryonic stem cell technology created by James Thomson at the University of Wisconsin-Madison.
• Stem cells show power to predict disease, drug toxicity Dec. 6, 2007 For the first time, scientists have used human embryonic stem cells to predict the toxic effects of drugs and provide chemical clues to diagnosing disease.
• UW-Madison scientists guide human skin cells to embryonic state Nov. 20, 2007 In a paper to be published Nov. 22 in the online edition of the journal Science, a team of University of Wisconsin-Madison researchers reports the genetic reprogramming of human skin cells to create cells indistinguishable from embryonic stem cells.
• Reprogramming the debate: stem-cell finding alters ethical controversy Nov. 20, 2007 When University of Wisconsin-Madison researchers succeeded in reprogramming skin cells to behave like embryonic stem cells, they also began to redefine the political and ethical dynamics of the stem-cell debate, a leading bioethicist says.
• $7.2 million grant to aid search for ALS stem cell therapy Sept. 20, 2007 With the help of a $7.2 million grant from the National Institutes of Health (NIH), a team of University of Wisconsin-Madison researchers will explore the potential of stem cells and natural growth factors to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.